Tiago Marques insider trades: Pasithea Therapeutics (KTTA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tiago reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | KTTA | ↑ Buy | 33,333 | $0.75 | $25K | Direct | Dec 1, 2025 (3d) |
| May 12, 2025 | KTTA | ↓ Sell | 960 | $0.82 | $792 | Direct | May 14, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KTTA insiders
Open-market trades in the last 12 months
About Tiago Marques's insider trades
Tiago Marques is Chief Executive Officer at Pasithea Therapeutics (KTTA). Since May 12, 2025, Tiago has reported 1 open-market purchase worth $25K and 1 sale worth $792 on SEC Form 4. In the last 12 months: 1 buy ($25K).
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KTTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.